Exousia Bio, Inc. Cash and Restricted Cash
Exousia Bio, Inc. (LMMY) had Cash and Restricted Cash of $0 as of 2026-02-28, per its 10-Q filed 2026-06-16.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-06-16
- 2026-02-28: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $0.00.
- 2025-11-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $0.00.
- 2025-08-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $0.00.
- 2025-05-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $0.00.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-02-28 | $0.00 10-Q · filed 2026-06-16 | |
| 2025-11-30 | $0.00 10-Q · filed 2026-03-17 | |
| 2025-08-31 | $0.00 10-Q · filed 2025-11-17 | |
| 2025-05-31 | $0.00 10-Q · filed 2026-06-16 | |
| 2025-02-28 | $1.03K 10-Q · filed 2026-06-16 | $0.00 10-Q · filed 2025-04-24 |
| 2024-11-30 | $1.03K 10-Q · filed 2026-03-17 | |
| 2024-08-31 | $1.03K 10-Q · filed 2025-11-17 | |
| 2024-05-31 | $1.03K 10-Q · filed 2026-06-16 | |
| 2024-02-29 | $1.03K 10-Q · filed 2025-04-24 | |
| 2023-11-30 | $1.03K 10-Q · filed 2025-01-10 | |
| 2023-08-31 | $1.32K 10-Q · filed 2024-10-11 | |
| 2023-05-31 | $7.86K 10-K · filed 2025-10-17 | |
| 2023-02-28 | $4.16K 10-Q · filed 2024-04-15 | |
| 2022-11-30 | $1.35K 10-Q · filed 2024-01-16 | |
| 2022-08-31 | $1.79K 10-Q · filed 2023-10-11 | |
| 2022-05-31 | $10.11K 10-K · filed 2024-08-30 | |
| 2022-01-31 | $0.00 10-K · filed 2023-09-01 |